Windward Capital Management CO Amgen Inc Transaction History

Windward Capital Management CO

  • $1.26 Billion
  • Q3 2024

A detailed history of Windward Capital Management CO transactions in Amgen Inc stock. As of the latest transaction made, Windward Capital Management CO holds 22,239 shares of AMGN stock, worth $5.85 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
22,239
Previous 21,683 2.56%
Holding current value
$5.85 Million
Previous $6.77 Million 5.77%
% of portfolio
0.57%
Previous 0.59%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
BUY
$309.38 - $337.38 $172,015 - $187,583
556 Added 2.56%
22,239 $7.17 Million
Q2 2024

Aug 06, 2024
SELL
$262.75 - $319.31 $93,013 - $113,035
-354 Reduced 1.61%
21,683 $6.77 Million
Q1 2024

Sep 20, 2024
BUY
$268.87 - $324.56 $95,179 - $114,894
354 Added 1.63%
22,037 $6.27 Million
Q1 2024

May 07, 2024
SELL
$268.87 - $324.56 $19,896 - $24,017
-74 Reduced 0.33%
22,037 $6.27 Million
Q4 2023

Oct 03, 2024
SELL
$255.7 - $288.46 $9,972 - $11,249
-39 Reduced 0.18%
22,111 $6.37 Million
Q4 2023

Jan 16, 2024
SELL
$255.7 - $288.46 $9,972 - $11,249
-39 Reduced 0.18%
22,111 $6.37 Million
Q3 2023

Oct 03, 2024
BUY
$218.65 - $271.46 $102,109 - $126,771
467 Added 2.15%
22,150 $5.95 Million
Q3 2023

Oct 20, 2023
SELL
$218.65 - $271.46 $56,630 - $70,308
-259 Reduced 1.16%
22,150 $5.95 Million
Q2 2023

Jul 18, 2023
SELL
$214.27 - $253.37 $23,783 - $28,124
-111 Reduced 0.49%
22,409 $4.98 Million
Q1 2023

Apr 24, 2023
BUY
$225.79 - $275.2 $71,349 - $86,963
316 Added 1.42%
22,520 $5.45 Million
Q3 2022

Oct 14, 2022
BUY
$224.46 - $253.15 $5,611 - $6,328
25 Added 0.11%
22,204 $5.01 Million
Q2 2022

Jul 08, 2022
BUY
$230.71 - $256.74 $30,453 - $33,889
132 Added 0.6%
22,179 $5.4 Million
Q1 2022

Apr 20, 2022
SELL
$219.27 - $242.57 $11,402 - $12,613
-52 Reduced 0.24%
22,047 $5.33 Million
Q4 2021

Jan 14, 2022
BUY
$198.88 - $227.6 $5,369 - $6,145
27 Added 0.12%
22,099 $4.97 Million
Q3 2021

Oct 12, 2021
SELL
$212.27 - $248.7 $12,099 - $14,175
-57 Reduced 0.26%
22,072 $4.69 Million
Q2 2021

Jul 19, 2021
SELL
$233.58 - $259.14 $13,547 - $15,030
-58 Reduced 0.26%
22,129 $5.39 Million
Q1 2021

Apr 15, 2021
SELL
$221.91 - $258.6 $11,095 - $12,930
-50 Reduced 0.22%
22,187 $5.52 Million
Q4 2020

Jan 21, 2021
SELL
$216.38 - $257.67 $672,725 - $801,096
-3,109 Reduced 12.27%
22,237 $5.11 Million
Q3 2020

Oct 13, 2020
SELL
$234.65 - $260.95 $88,463 - $98,378
-377 Reduced 1.47%
25,346 $6.44 Million
Q2 2020

Jul 20, 2020
SELL
$197.81 - $242.74 $56,969 - $69,909
-288 Reduced 1.11%
25,723 $6.07 Million
Q1 2020

Apr 14, 2020
SELL
$182.24 - $241.7 $180,599 - $239,524
-991 Reduced 3.67%
26,011 $5.27 Million
Q4 2019

Jan 14, 2020
SELL
$189.21 - $243.2 $27,057 - $34,777
-143 Reduced 0.53%
27,002 $6.51 Million
Q3 2019

Oct 15, 2019
SELL
$174.11 - $208.62 $1,044 - $1,251
-6 Reduced 0.02%
27,145 $5.25 Million
Q2 2019

Jul 11, 2019
SELL
$166.7 - $195.41 $71,514 - $83,830
-429 Reduced 1.56%
27,151 $5 Million
Q1 2019

Apr 12, 2019
BUY
$180.87 - $203.88 $3,255 - $3,669
18 Added 0.07%
27,580 $5.24 Million
Q4 2018

Jan 15, 2019
BUY
$178.4 - $208.25 $24,976 - $29,155
140 Added 0.51%
27,562 $5.37 Million
Q3 2018

Oct 10, 2018
SELL
$185.29 - $208.89 $44,284 - $49,924
-239 Reduced 0.86%
27,422 $5.69 Million
Q2 2018

Jul 12, 2018
SELL
$166.05 - $186.51 $15,442 - $17,345
-93 Reduced 0.34%
27,661 $5.11 Million
Q1 2018

Apr 12, 2018
SELL
$169.43 - $198.0 $6,099 - $7,128
-36 Reduced 0.13%
27,754 $4.73 Million
Q4 2017

Jan 11, 2018
SELL
$168.79 - $188.59 $27,343 - $30,551
-162 Reduced 0.58%
27,790 $4.83 Million
Q3 2017

Oct 17, 2017
BUY
$167.29 - $191.0 $4.68 Million - $5.34 Million
27,952
27,952 $5.21 Million

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Windward Capital Management CO Portfolio

Follow Windward Capital Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Windward Capital Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Windward Capital Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email